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Abstract
The use of the halide-sensitive fluorescent probes (6-methoxy-N-( sulphopropyl)quinolinium (SPQ) and N-(ethoxycarbonylmethyl)-6-
methoxyquinolinium bromide (MQAE)) to measure chloride transport in cells has now been established as an alternative to the halide-
selective electrode technique, radioisotope efflux assays and patch-clamp electrophysiology. We report here procedures for the assessment of
halide efflux, using SPQ/MQAE halide-sensitive fluorescent indicators, from both adherent cultured epithelial cells and freshly obtained
primary human airway epithelial cells. The procedure describes the calculation of efflux rate constants using experimentally derived SPQ/
MQAE fluorescence intensities and empirically derived Stern–Volmer calibration constants. These fluorescence methods permit the
quantitative analysis of CFTR function.
D 2004 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
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1. Overview
The use of the quinolinium salt-based halide-sensitive
fluorescent probes (6-methoxy-N-( sulphopropyl)quino-
linium (SPQ) and N-(ethoxycarbonylmethyl)-6-methoxyqui-
nolinium bromide (MQAE)) to measure chloride (Cl)
transport in epithelial cells has now been established as an
alternative to the halide-selective electrode technique, radio-
isotope efflux assays and patch-clamp electrophysiology. In
the assay introduced by Verkman and colleagues, halide
secretion is followed by measuring the dequenching of
intracellular SPQ/MQAE fluorescence by the effluxing ha-
lide in response to stimulation of a specific agonist-mediated
cellular Cl secretion mechanism [1–3]. In general, cells
attached to a coverslip are loaded with SPQ/MQAE, the
extracellular dye is washed off, and the cells are transferred to
a superfusion chamber on a fluorescent microscope and
fluorescence imaging performed. Images are saved for off-
line analysis, and SPQ/MQAE fluorescence intensity for each
region of interest (ROI) is compared over time or treatment.
Many studies have used the fluorescence indicators to assess
actual Cl channel efflux. Iodide is increasingly used as a Cl
surrogate chiefly because indicator fluorescence is more
effectively quenched by I than by Cl (halide ion selectiv-
ity: I>Br>Cl) thus improving the signal to noise ratio in
SPQ/MQAE spectrofluorimetry. To date, SPQ/MQAE spec-
trofluorimetry has been used in numerous studies to assess
halide efflux in adherent cultured cell lines [4,5,7–11]. In
1569-1993/$ - see front matter D 2004 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
doi:10.1016/j.jcf.2004.05.036
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contrast, the use of the technique for measurement of halide
channel activity in primary epithelial cells is more technically
demanding, reflected by the paucity of examples in the
literature [3,4,7,10–13]. Below is a description of each step
in the procedure to image halide-sensitive fluorescence in (A)
adherent cultured epithelial cell lines, and (B) freshly
obtained primary epithelial cells.
2. Purpose
This procedure provides guidelines and procedures and
the interpretation of the results used for the assessment of
Cl or I efflux, using SPQ/MQAE halide-sensitive fluo-
rescent indicators, from both adherent cultured epithelial
cell lines and freshly obtained primary human airway
epithelial cells. The operating procedures start with the
setting up of the epi-fluorescence digital imaging micro-
scope together with experimental materials (including epi-
thelial cells attached to coverslips), and ends with the
calculation of efflux rate constants using experimentally
derived SPQ/MQAE fluorescence intensities and empirical-
ly derived Stern–Volmer calibration constants.
3. Measurement of iodide efflux from adherent cultured
epithelial cell lines1
3.1. Materials and solutions
Efflux solution (mM): 135 NaNO3; 1 Ca2SO4; 1 Mg2
SO4; 2.4 K2HPO4; 0.6 KH2PO4; 10 HEPES, 10 glucose; pH
7.4. Iodide solution: 135 mM NaI in the above efflux buffer
replaced the NaNO3. Cyclic AMP elevating agent forskolin
(FSK) and the phosphodiesterase inhibitor 3-isobutyl-1-
methylxanthine (IBMX). Quenching solution: Iodide solu-
tion: Iodide buffer supplemented with 150 mM KSCN.
Ionophores: Ionomycin and valinomycin (25 mM working
stocks made up in analytical grade ethanol and stored at
 20 jC).
3.2. Preparation of cells and attachment to coverslips
Acid-washed coverslips are prepared by incubation in hot
HCl (1 N, 2–4 h at 60 jC), followed by rinsing in distilled
water and ethanol before drying. The coverslips are then
UV-sterilized prior to use. Cells (seeding density 1104
cells/35-mm dish) are allowed to attach to sterile acid-
washed glass coverslips by conventional cell culture in a
5% CO2 atmosphere at 37 jC in appropriate growth media
at least 3–4 days prior to use.
3.3. Loading cells with SPQ/MQAE2
3.3.1. Metabolic loading
Incubate cells with SPQ solution for 12 h prior to assay
(556 Al of 36 mM stock per 1.5 ml cell growth media will
give 10 mM final SPQ concentration).
3.3.2. Hypotonic loading
To eliminate any possible fluorescent ‘hotspots’ due to
preferential subcellular localisation of SPQ, cells can be
loaded with SPQ via hypotonic shock (50% for 4 min). The
hypotonic loading buffer contains 0.56 ml of 36 mM SPQ
stock with 1 ml of filtered deionised water and 0.44 ml of
NaNO3 solution (2 ml total volume).
3.4. Experimental procedure
Coverslips with SPQ/MQAE-loaded cells are inserted
into a perfusion chamber mounted on the stage of a
Nikon Diaphot 300 inverted microscope (Nikon) and
continual perfusion is initiated (140 Al volume and flow
rate of 3.2 ml/min with complete buffer exchange
achieved in approximately 2.6 s). Cells are illuminated
with a 100 W xenon (Xe) arc lamp with neutral density
filter attenuation. The cells are viewed first using a Nikon
10 fluorescence objective and the fluorescence imaged
with a 40 Nikon fluorescence 1.4 N.A. objective onto
an intensified charge-coupled device (CCD) camera
(C2400-68, Hamamatsu Photonics) through a D460/50
band-pass filter (Glen Spectra). Once a suitable field of
view is found, the main experiment is started by exten-
sive washing with NaNO3 solution to remove extraneous
SPQ/MQAE. The frame acquisition rate for all the data is
30 s with an exposure time of 15 ms/frame. At time t= 0
min, the maximal fluorescence is measured over 5 min in
efflux solution (Fig. 1A). Intracellular SPQ is then
quenched by perfusion for a further 15 min with iodide
solution. At time t= 20 min, the establishment of basal
fluorescence is achieved by substitution of nitrate (an
anion transported by CFTR that does not quench SPQ)
for I. Cyclic AMP (20 AM FSK and 100 AM IBMX)
agonist stimulation of the cells then follows at time t = 25
min and autofluorescence is finally measured by complete
quenching of the intracellular SPQ at time t = 45 min with
quenching solution containing KSCN (150 mM) and
valinomycin (5 AM) after 30 min to obtain the minimum
fluorescence (Fig. 1A).
3.5. Image analysis
Data are acquired and analysed off-line using Meta-
morphk Image software (Universal Imaging). The average
2 At room temperature in the dark.
1 Procedure as used in the Department of Gene Therapy, Imperial
College London, UK (performed in dark room at room temperature).
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fluorescence intensity of each region of interest (ROI, drawn
along the perimeter of a cell) for each of the frames is
determined and directly logged into a spreadsheet. These
ROI average fluorescence intensities are then used to
assemble fluorescence traces (arbitrary fluorescence units
as a function of time) as shown in Fig. 1B and C.
3.5.1. Calculation of iodide efflux rates
Iodide efflux rates ( JI, mM/s) are calculated from the
observed fluorescence changes as detailed previously [1].
Computation of these rates requires knowledge of the Stern–
Volmer constant (KI) for quenching of intracellular SPQ by I

(calibration of SPQ fluorescence vs. intracellular I concen-
tration). The Stern–Volmer constants (M1) for the common-
ly used cell lines, 16HBE14o, C127 (+/+) and (/), are
15.1F 2.6, 10.2F 1.5, and 15.4F 6.7 (mean ± SEM, n= 6),
respectively.
The rate of I efflux (dI/dt) is calculated as JI from Eq. (1).
JI ðmM=sÞ ¼ ðF0=KIF2ÞðdF=dtÞ ð1Þ
where KI is the Stern–Volmer constant for quenching of
intracellular SPQ by I as determined above. dF/dt is the
initial rate of change of SPQ fluorescence (t = 10 minus 2 min
after agonist addition). F0 is determined from the difference
in fluorescence signal measured in cells in zero iodide buffer
and after addition of KSCN/valinomycin (Fig. 2).
4. Measurement of halide efflux from primary epithelial
cells from human nasal and bronchial brushings—
protocol 13
4.1. Specific materials and solutions
Efflux buffer: Standard Ringer’s (SR) solution (mM):
140 NaCl; 5 KCl; 5 HEPES; 1 MgCl2; 1.5 CaCl2; 5 glucose;
pH 7.4. Chloride-free nitrate buffer (NO3 in the above SR
buffer replacing all Cl). Quenching solution buffer: SR
solution containing 150 mM KSCN and 10 mM HEPES,
pH 7.4. For the intracellular calibration, a K+-rich buffer
containing (mM): 120 K; 5 HEPES; 5 glucose; 1 MgCl2
and various concentrations of Cl and NO3
 is used at pH
3 Procedure as used in the Department of Gene Therapy, Imperial
College London, UK (performed in dark room at room temperature).
Fig. 1. Typical cyclic AMP-induced I efflux from a pair of wild-type CFTR stably expressing (C127 +/+) or control (expressing vector alone, C127  / )
mouse mammary epithelial cell monolayers (A) Representative pseudo-colour fluorescent images of SPQ-loaded C127 (+/+) and ( / ) cells (original
magnification  600). Colour corresponds to fluorescence intensity in ascending order: blue, green, yellow, red and white. Data represents the meanF S.E.M.,
of the relative fluorescence ( F/F0) imaged from 10 randomly selected cells, where F is the observed SPQ fluorescence and F0 the fluorescence in the absence
of I (maximal fluorescence) measured initially for 2 min in buffer (consisting of 135 mM NaNO3, 1 mM Ca2SO4, 2.4 mM K2HPO4, 0.6 mM KH2PO4, 10 mM
HEPES and 10 mM glucose). Following a 20-min incubation, basal fluorescence was measured for 5 min after substitution of nitrate for I. At time t = 5 min,
C127 (+/+) (B) or C127 ( / ) (C) were stimulated with FSK (20 AM)/IBMX (100 AM). Intracellular SPQ was completely quenched by addition of I
containing KSCN (150 mM) and valinomycin (5 AM) after 30 min to obtain the minimum fluorescence.
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7.2. Ionophores: tributyltin and nigericin. The osmotic
strength of the solutions is calculated to be in the range
of 307–310 mosM and routinely validated by freezing-
point osmometry (Fiske Micro-osmometer, Fiske Associ-
ates, USA).
4.2. Primary nasal epithelial cells
Nasal epithelial cells are harvested from the inferior nasal
turbinate of patients detailed elsewhere [6].
4.3. Bronchial epithelial cells
Bronchial epithelial cells are obtained from non-CF
subjects undergoing flexible fibre-optic bronchosopy for
diagnostic purposes [4]. Brushings are taken from three
different bronchial sites (main stem or segmental) distant
from any pathology, using a cytology brush, introduced via
the biopsy channel of the bronchoscope. Brushings are
immediately placed in ice-cold DMEM (Invitrogen Life
Technologies) and transported to the laboratory on ice,
before washing and loading with fluorescent dye as de-
scribed above.
4.4. Coating of coverslips with Cell Takk cell adhesive
Cell-Takk (BD Biosciences) adhesive protein adsorbs to
the first surface it comes into contact with when its pH is
raised from acidic (comes in 5% acetic acid solution) to
neutral. A small amount of Cell-Takk is neutralised with
sodium bicarbonate (0.1M) and the acid-washed coverslips
coated with it. After 60 min, the coverslip is rinsed with
PBS prior to use.
4.5. Cell attachment
Prior to use, the primary cells are centrifuged down at
1600 g for 1 min, resuspended in 50 Al 37 jC SR buffer, and
loaded with dye by incubating for 40 min in 10 mM MQAE
(in SR buffer) in a cell culture incubator. The loaded cells
are rinsed with fresh SR and centrifuged at 1600 g for 1 min
and resuspended in 4 Al SR (37 jC). Dye-loaded cells are
seeded directly on to coverslip mounted on the microscope
stage.
4.6. Measurement of halide efflux from primary epithelial
cells from human nasal and bronchial brushings –
protocol 2 4
The loaded cells are placed on the Cell Takk-treated
coverslip and allowed to attach for a few min and are then
bathed in SR. Cell clusters with beating cilia are chosen for
analysis. Cells are perfused continually using a peristaltic
pump (Ismatec, Zurich, Switzerland) (30 mm3 exchange
volume and flow rate of 1 ml/min with complete buffer
exchange achieved in approximately 2 s). The frame acqui-
sition rate for all the data is 3–7 s with an exposure time of
16 ms/frame. At the end of the experiment, ROIs corres-
ponding to single cells or clusters are selected and the
average intensity of fluorescence cells determined. At
40 magnification, the fluorescence of the cells is homog-
enous and the dye does not show compartmentalisation,
therefore the average intensity is a good indicator of MQAE
fluorescence. The fluorescence is displayed as arbitrary
units, after the background subtraction and, if necessary,
correction for dye leakage and bleaching.
The experiment is performed sequentially, by exposing
the cells to a Cl gradient under basal conditions, followed
by cAMP (100 AM IBMX and 5 AM FSK) agonist stimu-
lation, and subsequent in situ double-point calibration and
determination of autofluorescence. The quenching solution
consists of 150 mM KSCN in 10 mM HEPES, pH 7.2.
4.7. In situ double-point calibration
MQAE fluorescence is linearly related to intracellular
[Cl]i according to the Stern–Volmer equation:
½CliðtÞ ¼
F0
FCl;t
 1
 
 1
KSV
ð2Þ
F0 is the fluorescence in the absence of Cl
 after subtraction
of background fluorescence, FCl,t is the fluorescence in the
presence of [Cl]i after subtraction of background fluores-
cence and KSV is the Stern–Volmer constant for Cl

quenching. KSV is determined by double-point calibration,
which is carried out as follows.
The cells are exposed to the K+-rich buffer described
above containing the ionophores tributyltin (10 AM) and
nigericin (10 AM). After this treatment, the intracellular
4 Procedure as used in the Department of Medical Cell Biology
University of Uppsala, Uppsala, Sweden (performed in dark room at 37 jC)
[7–9].
Fig. 2. Typical cyclic AMP-induced I efflux from a pair of wild-type
CFTR stably expressing (C127 +/+) or control (expressing vector alone,
C127  / ) mouse mammary epithelial cell monolayers. The relative
fluorescence ( F/F0) from a field of 10–20 cells was determined as in Fig.
1A and B. Cells were stimulated with: FSK (20 AM)/IBMX (100 AM).
Efflux rates ( JI, mM/s) were calculated using Eq. (1) with Stern–Volmer
constants (KI) for intracellular SPQ fluorescence quenching by I
.
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Cl concentration equals the extracellular Cl concentra-
tion. If the experiment is carried out at, e.g., 20 and 80
mM Cl, KSV can be calculated from Eq. (2). Subsequent-
ly, this value of KSV can be used to calculate [Cl
]i during
the experiment.
In practice, it is difficult to obtain F0, because the cells
may be damaged by prolonged exposure to an extracellular
Cl concentration of 0. Therefore, F20 (which is the
fluorescence at 20 mM [Cl]i) is determined experimentally
and then F0 can be calculated from it.
In order to calculate the efflux rate, we use an exponen-
tial fitting (Fig. 3) of the experimental data. Due to the
electroneutral characteristics of the Cl efflux in non-excit-
able epithelial cells, the intracellular Cl concentration
during the efflux ([Cl]i(t)) is described by the equation:
½CliðtÞ ¼ Bottomþ ðPlateau BottomÞ  expðKtÞ
where Bottom is [Cl]i at the end of the efflux, Plateau is
[Cl]i before the efflux, t is the elapsed time from the
Fig. 3. The effect of cAMP agonists on the chloride efflux in (A) BHK-wt CFTR cells and (B) BHK-F508del-CFTR cells. The data show that the response in
wt-CFTR cells is much larger than the response in F508del-CFTR cells. The rectangle above the time axis indicates the Cl concentration (mM) in the bathing
solution. The stimulated efflux was obtained in the presence of 5 AM FSK and 100 AM IBMX for the entire length of the indicated trace. The symbols indicate
experimental data, while the drawn lines and the parameters Plateau, Bottom, K and R2 were obtained by computer-aided fitting to an exponential function.
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beginning of the efflux, and K is the permeability constant
of the membrane for Cl.
The Cl efflux rate JCl is then described by the equation:
JCl ¼ d½Cli=dt ¼ KðPlateau BottomÞexpðKtÞ
In addition, the extreme of this function is K(Plateau
Bottom), representing the maximal Cl efflux.
The successive exposure of the same cells to different
conditions allows a powerful and meaningful comparison of
the effects of agonists in a paired-way fashion. This is true
especially when cells behave heterogeneously and the
variability of responses impairs statistical analyses. At the
same time, it offers an advantage when scarce and sensitive
material such as cells collected from human donors is to be
examined. Although there are reports that cells behave
differently after successive exposure to a Cl gradient
[14], in our experience, the nasal cells and most of the cells
lines are not affected.
5. Additional notes
(a) All buffers/solutions should be filtered through a
0.2-Am pore-size filter prior to use to minimise light
scatter. (b) Validated equipment, supplies and reagents
are listed in the appendix of the on-line version of the
article in the virtual repository. (c) Care should be taken
to avoid photobleaching caused by extended periods of
illumination. In addition, the deleterious effects of heat
from the microscope mercury and/or Xe arc lamp sources
are minimised by use of appropriate neutral density filters
and use of objective especially modified to correct for
optic aberration due to heating. (d) Local ethics and
regulatory authority approval should be obtained before
the use of human biological material.
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